These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 4371315

  • 1. Immunotherapy of guinea pig cancer with BCG.
    Zbar B, Rapp HJ.
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract] [Full Text] [Related]

  • 2. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract] [Full Text] [Related]

  • 3. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    Zbar B, Ribi E, Meyer T, Azuma I, Rapp HJ.
    J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
    [No Abstract] [Full Text] [Related]

  • 4. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract] [Full Text] [Related]

  • 5. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E, Peters L, Rapp HJ, Hanna MG, Hunter JT.
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy with nonviable microbial components.
    Ribi E, Milner KC, Granger DL, Kelly MT, Yamamoto K, Brehmer W, Parker R, Smith RF, Strain SM.
    Ann N Y Acad Sci; 1976 May; 277(00):228-38. PubMed ID: 187099
    [Abstract] [Full Text] [Related]

  • 7. [Immunotherapy of cancer with BCG].
    Yamamura Y, Azuma I.
    Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
    [No Abstract] [Full Text] [Related]

  • 8. Immunotherapy of guinea pig cancer with BCG.
    Zbar B.
    Johns Hopkins Med J Suppl; 1974 Mar; 3():121-30. PubMed ID: 4608693
    [No Abstract] [Full Text] [Related]

  • 9. BCG and cancer (first of two parts).
    Bast RC, Zbar B, Borsos T, Rapp HJ.
    N Engl J Med; 1974 Jun 20; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract] [Full Text] [Related]

  • 10. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE, Meyer TJ, Azuma I, Zbar B.
    Natl Cancer Inst Monogr; 1973 Dec 20; 39():115-9. PubMed ID: 4595311
    [No Abstract] [Full Text] [Related]

  • 11. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP, Zbar B, Rapp HJ.
    J Natl Cancer Inst; 1975 Feb 20; 54(2):515-7. PubMed ID: 234537
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.
    Zbar B, Tanaka T.
    Science; 1971 Apr 16; 172(3980):271-3. PubMed ID: 4323415
    [Abstract] [Full Text] [Related]

  • 13. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
    Meyer TJ, Ribi EE, Azuma I, Zbar B.
    J Natl Cancer Inst; 1974 Jan 16; 52(1):103-11. PubMed ID: 4359409
    [No Abstract] [Full Text] [Related]

  • 14. Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).
    Bekierkunst A.
    Int J Cancer; 1975 Sep 15; 16(3):442-7. PubMed ID: 170221
    [Abstract] [Full Text] [Related]

  • 15. Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).
    Minden P, Wainberg M, Weiss DW.
    J Natl Cancer Inst; 1974 May 15; 52(5):1643-5. PubMed ID: 4364739
    [No Abstract] [Full Text] [Related]

  • 16. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
    McLaughlin CA, Cantrell JL, Ribi E, Goldberg EP.
    Cancer Res; 1978 May 15; 38(5):1311-6. PubMed ID: 205361
    [Abstract] [Full Text] [Related]

  • 17. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets.
    Bartlett GL, Zbar B.
    J Natl Cancer Inst; 1973 May 15; 50(5):1385-90. PubMed ID: 4351399
    [No Abstract] [Full Text] [Related]

  • 18. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    Natl Cancer Inst Monogr; 1972 Dec 15; 35():345-58. PubMed ID: 4349152
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.